0001104659-19-033437.txt : 20190603
0001104659-19-033437.hdr.sgml : 20190603
20190603160034
ACCESSION NUMBER: 0001104659-19-033437
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190530
FILED AS OF DATE: 20190603
DATE AS OF CHANGE: 20190603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Van der Ploeg Leonardus H.T.
CENTRAL INDEX KEY: 0001615726
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 19873244
MAIL ADDRESS:
STREET 1: 101 HAMMOND STREET
CITY: NEWTON
STATE: MA
ZIP: 02467
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 11TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 11TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
a4.xml
4
X0306
4
2019-05-30
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001615726
Van der Ploeg Leonardus H.T.
222 BERKELEY STREET, SUITE 1200
BOSTON
MA
02116
0
1
0
0
Chief Scientific Officer
Common Stock
2019-05-30
4
M
0
5000
4.59
A
47339
D
Common Stock
2019-05-30
4
S
0
5000
25.31
D
42339
D
Common Stock
2019-05-31
4
M
0
5000
4.59
A
47339
D
Common Stock
2019-05-31
4
S
0
5000
25.10
D
42339
D
Employee Stock Option (Right to Buy)
4.59
2019-05-30
4
M
0
5000
0
A
2025-11-16
Common Stock
5000
13611
D
Employee Stock Option (Right to Buy)
4.59
2019-05-31
4
M
0
5000
0
A
2025-11-16
Common Stock
5000
8611
D
This transaction was executed in multiple trades at prices ranging from $25.11 to $25.64, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $25.00 to $25.33, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
/s/ Hunter S. Smith, attorney-in-fact for Leonardus H.T. Van der Ploeg
2019-06-03